Page 4 - Data From News Today

Rami Komrokji, MD, summarizes data presented at ASCO 2023 from the COMMANDS trial on the role of luspatercept in lower-risk MDS.

New data drawn from the EUSTAR database made clear several key insights into this subset of systemic sclerosis patients, with survival and skin manifestations being highlighted.

COPENHAGEN, Denmark--(BUSINESS WIRE)--Jun 27, 2023--

Company Announcement Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage with global regulatory authorities...

/PRNewswire/ -- AbbVie (NYSE: ABBV) and Genmab (Nasdaq: GMAB) today announced topline results from the follicular lymphoma (FL) cohort of the Phase 1/2 EPCORE™...

Stormy market conditions strained the nation’s largest home builders in 2022, and they’re bracing for more uncertainty, says the 2023 Housing Giants report

AST SpaceMobile has conducted a successful test of 4G LTE data service from its test satellite in orbit to a standard, unmodified smartphone using an existing AT&T cellular frequency band. The test "achieved repeated successful download speeds above 10 Mbps", proving the system is capable of more than just basic voice and messaging service. The test took place in Hawaii. The company has previously conducted successful tests of voice ...

Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.

Results from phase 1/2 EPCORE NHL-2 trial investigating epcoritamab in combination with rituximab-lenalidomide (R2) showed a 98 percent overall response rate (ORR), 87 percent complete metabolic

BEIJING, June 8 (Xinhua) -- China export container shipping index edged up in May, data from the Shanghai Shipping Exchange showed. The average China Containeri